Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04094025 · ClinicalTrials.gov registry record · Phase 1
Irritation and Sensitization Study of d-Amphetamine Transdermal System
A Phase 1 study, sponsored by Noven Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 229
- Enrollment target
NCT04094025 is a Phase 1 study that has completed, run by Noven Therapeutics. The registered enrollment target is 229 participants.
The verdict
NCT04094025, a Phase 1 study, has completed, sponsored by Noven Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 229 participants
- Enrollment target
Study Summary
The study will assess skin irritation as well as sensitization for d-ATS patch in healthy subjects.
Interventions
- DRUG dATS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2020-05-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04094025
The ClinicalTrials.gov registry entry for NCT04094025 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noven Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dATS is the first listed.
NCT04094025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04094025 about?
NCT04094025 is a clinical study titled "Irritation and Sensitization Study of d-Amphetamine Transdermal System". The study will assess skin irritation as well as sensitization for d-ATS patch in healthy subjects.
What is the current status of trial NCT04094025?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 229 participants. The study started on 2019-12-02. Estimated completion is 2020-05-16.
What interventions are being tested in trial NCT04094025?
The interventions under investigation include: dATS (DRUG).
Who is sponsoring clinical trial NCT04094025?
This trial is sponsored by Noven Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.